Literature DB >> 33516403

Implications of Inflammation and Fibrosis in Atrial Fibrillation Pathophysiology.

Masahide Harada1, Stanley Nattel2.   

Abstract

Inflammation and fibrosis have been implicated in the pathophysiology of atrial fibrillation. Atrial fibrosis causes conduction disturbances and is a central component of atrial remodeling in atrial fibrillation. Cardiac fibroblasts, the cells responsible for fibrosis formation, are activated by inflammatory mediators and growth factors associated with systemic inflammatory conditions. Thus, inflammation contributes to atrial fibrosis; the complex interplay of these maladaptive components creates a vicious cycle of atrial remodeling progression, maintaining atrial fibrillation and increasing thrombogenicity. This review provides up-to-date knowledge regarding inflammation and fibrosis in atrial fibrillation pathophysiology and their potential as therapeutic targets.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Atrial remodeling; Fibrosis; Inflammasome; Inflammation

Year:  2021        PMID: 33516403     DOI: 10.1016/j.ccep.2020.11.002

Source DB:  PubMed          Journal:  Card Electrophysiol Clin        ISSN: 1877-9182


  8 in total

1.  Detection of atrial fibrosis using echocardiographic strain: a new pathway.

Authors:  Maria Mariana Barros Melo da Silveira; João Victor Batista Cabral; Amanda Tavares Xavier; Lucas Reis da Costa; Dhouglas José Ferreira do Nascimento; José Maria Del Castillo; Luydson Richardson da Silva Vasconcelos; Dário Celestino Sobral Filho; Dinaldo Cavalcanti de Oliveira
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-06-24       Impact factor: 1.712

2.  Atrial AMP-activated protein kinase is critical for prevention of dysregulation of electrical excitability and atrial fibrillation.

Authors:  Kevin N Su; Yina Ma; Marine Cacheux; Zeki Ilkan; Nour Raad; Grace K Muller; Xiaohong Wu; Nicole Guerrera; Stephanie L Thorn; Albert J Sinusas; Marc Foretz; Benoit Viollet; Joseph G Akar; Fadi G Akar; Lawrence H Young
Journal:  JCI Insight       Date:  2022-04-22

Review 3.  Evidence of Failed Resolution Mechanisms in Arrhythmogenic Inflammation, Fibrosis and Right Heart Disease.

Authors:  Rim Younes; Charles-Alexandre LeBlanc; Roddy Hiram
Journal:  Biomolecules       Date:  2022-05-19

Review 4.  Resolution-promoting autacoids demonstrate promising cardioprotective effects against heart diseases.

Authors:  Roddy Hiram
Journal:  Mol Biol Rep       Date:  2022-02-10       Impact factor: 2.742

5.  Plasma Galectin-3 is associated with progression from paroxysmal to persistent atrial fibrillation.

Authors:  Qianhui Wang; Li Xu; Ying Dong; Yuan Fu; Yuxia Pan; Qianran Luan; Ye Liu; Zheng Liu; Xinchun Yang; Mulei Chen; Yuanfeng Gao
Journal:  BMC Cardiovasc Disord       Date:  2021-05-02       Impact factor: 2.174

6.  Heart failure with preserved ejection fraction: An alternative paradigm to explain the clinical implications of atrial fibrillation.

Authors:  Jonathan P Ariyaratnam; Adrian D Elliott; Ricardo S Mishima; Celine Gallagher; Dennis H Lau; Prashanthan Sanders
Journal:  Heart Rhythm O2       Date:  2021-12-17

Review 7.  Atrial Fibrillation in Chronic Kidney Disease: An Overview.

Authors:  Sai Gadde; Revanth Kalluru; Swathi Priya Cherukuri; Rahul Chikatimalla; Thejaswi Dasaradhan; Jancy Koneti
Journal:  Cureus       Date:  2022-08-07

8.  Development and Validation of a Risk Nomogram Model for Predicting Recurrence in Patients with Atrial Fibrillation After Radiofrequency Catheter Ablation.

Authors:  Zhihao Zhao; Fengyun Zhang; Ruicong Ma; Lin Bo; Zeqing Zhang; Chaoqun Zhang; Zhirong Wang; Chengzong Li; Yu Yang
Journal:  Clin Interv Aging       Date:  2022-09-25       Impact factor: 3.829

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.